A. Almquist

发表

Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study.

David L Hayes, D. Cannom, D. Hayes, 2007, Heart rhythm.

Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy.

B. Maron, C. Gornick, R. Hauser, 2005, Heart rhythm.

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

J. Seidman, J. Saul, W. Roberts, 2009, JAMA.

Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.

W. Pedersen, M. Pritzker, D. Benditt, 1989, The American journal of cardiology.

Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction.

J. Blankenship, A. Almquist, 1989, Journal of the American College of Cardiology.

Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction

Robert G. Hauser, C. Gornick, R. Hauser, 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Unexpected ICD Pulse Generator Failure Due to Electronic Circuit Damage Caused by Electrical Overstress

V. Parsonnet, D. Hayes, M. Schoenfeld, 2001, Pacing and clinical electrophysiology : PACE.

Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi.

R. V. Van Tassel, I. Goldenberg, M. Mooney, 1990, The American journal of cardiology.

Clinical Outcome and Phenotypic Expression in LAMP 2 Cardiomyopathy

J. Seidman, J. Saul, W. Roberts, 2009 .

Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.

Jagmeet P. Singh, Shawn D. Feinstein, D. Delurgio, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Carotid sinus hypersensitivity: evaluation of the vasodepressor component.

C. Gornick, D. Benditt, A. Almquist, 1985, Circulation.

AV Node Bypass Tracts and Enhanced AV Conduction: Relation to Ventricular Preexcitation

D. Benditt, A. Almquist, D. Dunbar, 1986 .

Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.

M. Link, J. Hodges, B. Maron, 2009, Heart rhythm.

Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.

J. Hodges, B. Maron, K. Shannon, 2009, Heart rhythm.

Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope.

J. Lesser, D. Benditt, I. Goldenberg, 1989, The American journal of cardiology.

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

M. Link, B. Maron, M. Maron, 2003, Circulation.

Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.

C. Gornick, R. Hauser, L. Kallinen, 2010, Heart rhythm.

Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.

C. Gornick, R. Hauser, L. Kallinen, 2008, Heart rhythm.

Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart.

J. R. Schmid, C. Gornick, D. Benditt, 1985, The American journal of cardiology.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2000, The New England journal of medicine.

Aborted Sudden Cardiac Death in Hypertrophic Cardiomyopathy

B. Maron, D. Rosenbaum, A. Almquist, 1999, Journal of cardiovascular electrophysiology.

Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator

Jagmeet P. Singh, Shawn D. Feinstein, D. Delurgio, 2015, Journal of Interventional Cardiac Electrophysiology.

Role of extrastimulus site and tachycardia cycle length in inducibility of atrial preexcitation by premature ventricular stimulation during reciprocating tachycardia.

W. S. Ring, D. Benditt, D. Benson, 1987, The American journal of cardiology.

Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope.

C. Gornick, D. Benditt, I. Goldenberg, 1989, The New England journal of medicine.

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

B. Maron, D. Aeppli, A. Almquist, 1999, JAMA.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

Role of Extrastimulus Site and Cycle length in lnducibility o Preexcitation by Premature Ventricular Stimulation During Reciprocatin

D. Woodrow, A. Almquist, H. Tobler, 1987 .

Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction.

C. Gornick, D. Benditt, A. Almquist, 1987, Circulation.

Single-chamber cardiac pacing with activity-initiated chronotropic response: evaluation by cardiopulmonary exercise testing.

C. Gornick, D. Benditt, D G Benditt, 1987, Circulation.

Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.

C. Gornick, R. Hauser, Charles C Gornick, 2007, Heart rhythm.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2007, JAMA.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

M. Link, E. Ashley, G. Boriani, 2013, Journal of the American College of Cardiology.

Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.

B. Maron, A. Almquist, Tammy S. Haas, 2005, Heart rhythm.

Learning from our mistakes? Testing new ICD technology.

R. Hauser, A. Almquist, 2008, The New England journal of medicine.

Electrophysiologic effects of papillary muscle traction in the intact heart.

C. Gornick, D. Benditt, A. Almquist, 1986, Circulation.

Altered calcium uptake by the sarcoplasmic reticulum following cardiac transplantation in humans.

M. Olivari, D. Benditt, A. Almquist, 1987, The Canadian journal of cardiology.

Cardioversion for intractable hiccups: a frightening cure.

D. Benditt, I. Goldenberg, A. Almquist, 1987, The New England journal of medicine.

Extreme hypertrophic cardiomyopathy

B. Maron, A. Almquist, S. Casey, 2003, Heart.

Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study

P. H. Beadle, A. Skadsen, S. Swiryn, 2002 .

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

J. Seidman, J. Saul, W. Roberts, 2009, JAMA.

Significance of Appropriate Defibrillator Shock 3 Hours and 20 Minutes Following Implantation in a Patient with Hypertrophic Cardiomyopathy

B. Maron, A. Almquist, Tammy S. Haas, 2008, Journal of cardiovascular electrophysiology.

Feasibility and Initial Results of an Internet‐Based Pacemaker and ICD Pulse Generator and Lead Registry

V Parsonnet, S Furman, D. Cannom, 2001, Pacing and clinical electrophysiology : PACE.

Learning from our mistakes? Testing new ICD technology.

R. Hauser, A. Almquist, 2008, The New England journal of medicine.